Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
Omeros To Present Narsoplimab Pivotal Trial Data At European Hematology Association Annual Congress Jun. 11-14
01:07pm, Thursday, 14'th May 2020Omeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress
01:00pm, Thursday, 14'th May 2020
Omeros Corporation (Nasdaq: OMER) today announced that the results of its pivotal trial of narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy will
Edited Transcript of OMER earnings conference call or presentation 11-May-20 8:30pm GMT
07:19pm, Tuesday, 12'th May 2020
Q1 2020 Omeros Corp Earnings Call
Omeros (OMER) Q1 2020 Earnings Call Transcript
10:01am, Tuesday, 12'th May 2020
All forward-looking statements involve risks and uncertainties that could cause the company's actual results to differ materially. Please refer to the special note regarding forward-looking statement
Omeros Corporation (OMER) CEO Greg Demopulos on Q1 2020 Results - Earnings Call Transcript
01:37am, Tuesday, 12'th May 2020
Omeros Corporation (NASDAQ:OMER) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Jennifer Williams – Investor Relations Greg Demop
Omeros (OMER) Reports Q1 Loss, Lags Revenue Estimates
10:55pm, Monday, 11'th May 2020
Omeros (OMER) delivered earnings and revenue surprises of -2.50% and -23.88%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Omeros Q1 EPS $(0.530) Misses $(0.340) Estimate, Sales $23.537M Miss $30.270M Estimate
08:12pm, Monday, 11'th May 2020Omeros Corporation Reports First Quarter 2020 Financial Results
08:02pm, Monday, 11'th May 2020
Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as wel
Omeros Corporation Reports First Quarter 2020 Financial Results
12:00am, Monday, 11'th May 2020
Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecul
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Should You Buy Omeros (OMER) Ahead of Earnings?
12:36pm, Friday, 08'th May 2020
Omeros (OMER) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020
11:00am, Tuesday, 05'th May 2020
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2020, on Monday, May 11, 2020, after the market closes
Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020
12:00am, Tuesday, 05'th May 2020
Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2020
InMode (INMD) to Post Q1 Earnings: What's in the Offing?
03:20pm, Friday, 01'st May 2020
InMode's (INMD) Q1 performance is likely to have been driven by developments in business segments amid coronavirus-led supply disruptions.
